Patient leaflet - Sugammadex Qilu 100 mg/ml solution for injection
1. What Sugammadex is and what it is used for
What Sugammadex is
Sugammadex contains the active substance sugammadex. This medicine is considered to be a Selective Relaxant Binding Agent since it only works with specific muscle relaxants, rocuronium bromide or vecuronium bromide.
What Sugammadex is used for
When you have some types of operations, your muscles must be completely relaxed. This makes it easier for the surgeon to do the operation. For this, the general anaesthetic you are given includes medicines to make your muscles relax. These are called muscle relaxants, and examples include rocuronium bromide and vecuronium bromide. Because these medicines also make your breathing muscles relax, you need help to breathe (artificial ventilation) during and after your operation until you can breathe on your own again.
This medicine is used to speed up the recovery of your muscles after an operation to allow you to breathe on your own again earlier. It does this by combining with the rocuronium bromide or vecuronium bromide in your body. It can be used in adults whenever rocuronium bromide or vecuronium bromide is used.
It can be used in newborn babies, infants, toddlers, children, adolescents (birth to 17 years) when rocuronium bromide is used.
2. What you need to know before Sugammadex is given
You must not be given Sugammadex
- if you are allergic to sugammadex or any of the other ingredients of this medicine (listed in section 6).
Tell your anaesthetist if this applies to you.
Warnings and precautions
Talk to your anaesthetist before Sugammadex is given
- if you have kidney disease or had in the past. This is important as sugammadex is removed from your body by the kidneys.
- if you have liver disease or have had it in the past.
- if you have fluid retention (oedema).
if you have diseases which are known to give an increased risk of bleeding (disturbances of blood clotting) or you take anticoagulation medicines.
Other medicines and Sugammadex
Tell your anaesthetist if you are taking, have recently taken or might take any other medicines. This medicine may affect other medicines or be affected by them.
Some medicines reduce the effect of Sugammadex
It is especially important that you tell your anaesthetist if you have recently taken:
- toremifene (used to treat breast cancer).
- fusidic acid (an antibiotic).
Sugammadex can affect hormonal contraceptives
This medicine can make hormonal contraceptives - including the ‘pill’, vaginal ring, implants or a hormonal IntraUterine System (IUS) - less effective because it reduces how much you get of the progestogen hormone. The amount of progestogen lost by using Sugammadex is about the same as missing one oral contraceptive pill.
- If you are taking the pill on the same day as Sugammadex is given to you, follow the instructions for a missed dose in the pill’s package leaflet.
- If you are using other hormonal contraceptives (for example a vaginal ring, implant or IUS) you should use an additional non-hormonal contraceptive method (such as a condom) for the next 7 days and follow the advice in the package leaflet.
Effects on blood tests
In general, this medicine does not have an effect on laboratory tests. However, it may affect the results of a blood test for a hormone called progesterone. Talk to your doctor if your progesterone levels need to be tested on the same day you receive Sugammadex.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your anaesthetist for advice before being given this medicine. You may still be given this medicine, but you need to discuss it first.
It is not known whether sugammadex can pass into breast milk. Your anaesthetist will help you decide whether to stop breast-feeding, or whether to abstain from treatment with this medicine, considering the benefit of breast-feeding to the baby and the benefit of this medicine to the mother.
Driving and using machines
This medicine has no known influence on your ability to drive and use machines.
Sugammadex contains sodium
This medicine contains up to 9.7 mg sodium (main component of cooking / table salt) in each ml. This is equivalent to 0.5 % of the recommended maximum daily dietary intake of sodium for an adult.
3. How Sugammadex is given
This medicine will be given to you by your anaesthetist, or under the care of your anaesthetist.
The dose
Your anaesthetist will work out the dose of sugammadex you need based on:
- your weight
- how much the muscle relaxant medicine is still affecting you.
The usual dose is 2-4 mg per kg body weight for patients of any age. A dose of 16 mg/kg can be used in adults if urgent recovery from muscle relaxation is needed.
How Sugammadex is given
This medicine will be given to you by your anaesthetist. It is given as a single injection through an intravenous line.
If you are given more Sugammadex than you should
As your anaesthetist will be monitoring your condition carefully, it is unlikely that you will be given too much Sugammadex. But even if this happens, it is unlikely to cause any problems.
If you have any further questions on the use of this medicine, ask your anaesthetist or other doctor.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If these side effects occur while you are under anaesthesia, they will be seen and treated by your anaesthetist.
Common: may affect up to 1 in 10 people
- cough
- airway difficulties that may include coughing or moving as if you are waking or taking a breath
- light anaesthesia - you may start to come out of deep sleep, so need more anaesthesia. This might cause you to move or cough at the end of the operation
- complications during your procedure such as changes in heart rate, coughing or moving
- decreased blood pressure due to the surgical procedure
Uncommon: may affect up to 1 in 100 people
- shortness of breath due to muscle cramps of the airways (bronchospasm) occurred in patients with a history of lung problems
- allergic (drug hypersensitivity) reactions - such as a rash, red skin, swelling of your tongue and / or throat, shortness of breath, changes in blood pressure or heart rate, sometimes resulting in a serious decrease of blood pressure. Severe allergic or allergic-like reactions can be life threatening. Allergic reactions were reported more commonly in healthy, conscious volunteers
- return of muscle relaxation after the operation
Not known: frequency cannot be estimated from the available data
- severe slowing of the heart and slowing of the heart up to cardiac arrest (heart failure) may occur when Sugammadex is administered
Reporting of side effects
If you get any side effects, talk to your anaesthetist or other doctor. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website:www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side affects you can help provide more information on the safety of this medicine.
5. How to store Sugammadex
Storage will be handled by healthcare professionals.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and on the label after ‘EXP’. The expiry date refers to the last day of that month.
Store below 30°C. Do not freeze. Keep the vial in the outer carton in order to protect from light.
After first opening and dilution, chemical and physical in-use stability has been demonstrated for 48 hours at 2°C to 25°C. From a microbiological point of view, the diluted product should be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2°C to 8°C, unless dilution has taken place in controlled and validated aseptic conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. Contents of the pack and other information
What Sugammadex contains
The active substance is sugammadex.
1 mL solution for injection contains sugammadex sodium equivalent to 100 mg sugammadex. Each vial of 2 mL contains sugammadex sodium equivalent to 200 mg sugammadex. Each vial of 5 mL contains sugammadex sodium equivalent to 500 mg sugammadex.
The other ingredients are hydrochloric acid 3.7% (for pH adjustment), sodium hydroxide (for pH adjustment) and water for injections.
What Sugammadex looks like and contents of the pack
Sugammadex is a clear and colourless to slightly yellow solution for injection. It comes in two different pack sizes, containing either 10 vials with 2 mL or 10 vials with 5 mL solution for injection.
Not all pack sizes may be marketed.
Marketing Authorisation Holder
QILU PHARMA SPAIN S.L.
Paseo de la Castellana 40, planta 8,
28046 Madrid,
Spain
Manufacturer
KYMOS, S.L.
Ronda de Can Fatjó,
7B (Parque Tecnológico del Vallès),
Cerdanyola del Vallès, 08290, Barcelona,
Spain
Eurofins Analytical Services Hungary Kft.
Anonymus utca 6, Budapest
H-1045,
Hungary
This leaflet was last revised in 06/2026.
The following information is intended for healthcare professionals only: For detailed information refer to the Summary of Product Characteristics of Sugammadex.
34120056411B